Release Date: 30/09/10 09:27 Summary: Dividend Declared / Contract of Sale / Full Year Accounts Price Sensitive: Yes Download Document 126.17KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status